KREBSBIO vs VIYASH: Stock Comparison

Krebs Biochemicals and Industries Limited vs Viyash Scientific Ltd

Live data: 22 July 2026, 3:04 PM IST • Source: NSE and company filings

Viyash Scientific Ltd is the larger company by market capitalisation. Krebs Biochemicals and Industries Limited shows a lower P/E and faster revenue growth, while Viyash Scientific Ltd shows a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Krebs Biochemicals and Industries Limited and Viyash Scientific Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KREBSBIO is more favourable on 3 of 11 scored metrics and VIYASH on 6These counts are context-free and are not an overall rating.

Key Differences

Market Cap
VIYASH is the larger company
₹11,242 Cr vs ₹117 Cr
P/E Ratio
KREBSBIO has a lower P/E
0x vs 65.27x
P/B Ratio
KREBSBIO has a lower P/B
0x vs 3.98x
EPS
VIYASH has higher earnings per share
₹4.06 vs ₹-7.85
Revenue Growth (TTM YoY)
KREBSBIO has faster revenue growth
11.6% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
129% vs 11.6%
Qtr Profit Growth
VIYASH has stronger quarterly profit growth
455% vs 71.7%
ROCE
VIYASH has a higher ROCE
19% vs -15.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKREBSBIOVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricKREBSBIOVIYASH
Live Price₹53.41₹257
Day Change-3.03%-3.07%
Volume1,99711.16 L
52-Week High₹82.49₹298
52-Week Low₹38.33₹178.13
Distance from 52W High-35.25%-13.76%

Valuation

MetricKREBSBIOVIYASH
Market Cap₹117 Cr₹11,242 Cr
P/E Ratio0x65.27x
P/B Ratio0x3.98x
EPS₹-7.85₹4.06
Book Value₹-75.5₹66.6
Dividend Yield0%0%

Growth

MetricKREBSBIOVIYASH
Revenue Growth (TTM YoY)11.6%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth11.6%129%
Qtr Profit Growth71.7%455%

Profitability & Leverage

MetricKREBSBIOVIYASH
ROE11%
ROCE-15.4%19%
Net Margin-71.35%6.57%
Operating Margin-23%19.1%
Debt to Equity0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKREBSBIOVIYASH
Promoter Holding72.74%0%
FII Holding0.5%2.94% 0.22 pp
DII Holding0%7.99% 0.63 pp
Public Holding26.76%27.67% 0.3 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Krebs Biochemicals and Industries Limited and Viyash Scientific Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.